Skip to main content

4 Result(s)

within Bayram Farisogullari Remove this filter

and

  1. No Access

    Article

    Do we consider enough the presence of triggering factors in the evaluation of patients with FMF? Triggering factors are highly prevalent in colchicine-resistant FMF patients

    The aim of the study is to investigate the frequency of triggering factors in colchicine-resistant and -responsive Familial Mediterranean Fever (FMF) patients as well as the effect of  interleukin (IL)-1 antag...

    Bayram Farisogullari, Levent Kilic, Gozde Kubra Yardimci… in Internal and Emergency Medicine (2024)

  2. Article

    Open Access

    Hematologic Malignancy Risk in Inflammatory Arthritis Patients Treated with TNF Inhibitors: The Real-Life Data from the HUR-BIO Registry

    This study aimed to assess the incidence of hematologic malignancy (HM) among inflammatory arthritis (IA) patients receiving tumor necrosis factor inhibitors (TNFi) compared with the general Turkish population.

    Emine Duran, Zeynep Ozge Ozturk, Emre Bilgin, Yahya Büyükaşık… in Rheumatology and Therapy (2023)

    Download PDF (547 KB) View Article

  3. No Access

    Article

    Biologics for immunoglobulin A vasculitis: targeting vasculitis or comorbid disease?

    In this study, we aimed to evaluate the clinical features and treatments, including the use of biological disease-modifying anti-rheumatic drugs (bDMARDs) in a large cohort of pediatric and adult immunoglobuli...

    Bayram Farisogullari, Muserref Kasap Cuceoglu… in Internal and Emergency Medicine (2022)

  4. No Access

    Article

    Real-world data on MTX tolerance with regimens used in children versus adults

    Methotrexate (MTX) is one of the most commonly used disease-modifying anti-rheumatic drugs which can cause gastrointestinal side effects. MTX intolerance is defined as gastrointestinal and behavioral symptoms ...

    Ummusen Kaya Akca, Bayram Farisogullari, Gozde Kubra Yardimci… in Clinical Rheumatology (2021)